Organigram Reports Steep Q2 Profitability Decline, $5.8M Impairment, and Revised FCF Guidance
Summary
Organigram Global reported a sharp drop in Q2 profitability and a $5.8 million impairment from U.S. hemp regulations, alongside a downgrade in free cash flow guidance, despite raising full-year revenue targets due to an acquisition.
Key Events
-
Q2 Profitability Plummets
Net revenue decreased 9% to $59.8 million, and Adjusted EBITDA fell 82% to $0.9 million year-over-year, resulting in a net loss of $0.9 million.
-
Significant Impairment Charge
The company recognized a $5.8 million impairment related to its U.S. hemp-derived products business due to new regulatory restrictions, which will effectively eliminate these products by November 2026.
-
Revised Fiscal 2026 Outlook
While full-year net revenue guidance was increased to exceed $350 million (incorporating the Sanity Group acquisition), free cash flow guidance was downgraded from positive to approximately break-even.
-
U.S. Cannabis Market Developments
The company is evaluating options for entering the U.S. medical cannabis market following the federal rescheduling of cannabis to Schedule III for approved products.
Analysis
Organigram Global reported a significant decline in Q2 Fiscal 2026 profitability, with net revenue down 9% and Adjusted EBITDA plummeting 82% year-over-year, resulting in a net loss. The company also recognized a $5.8 million impairment charge related to its U.S. hemp-derived products business due to new regulatory restrictions. While full-year revenue guidance was raised due to the recent Sanity Group acquisition, free cash flow guidance was downgraded from positive to approximately break-even. The company is exploring options for the U.S. medical cannabis market following federal rescheduling.
At the time of this filing, OGI was trading at $1.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178.6M. The 52-week trading range was $1.11 to $2.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.